Currently, there are various LAAs under study for AML patients, including WT1, FLT3, BCL-2, and Survivin, as these were the most interesting LAAs in the serologic analysis of a recombinant cDNA expression library (SEREX) with screening using sera from AML patients [11]. Here, BCL2 is linked to acute myeloid leukemia.